PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-Nov-2020 Relief Therapeutics and NeuroRx announce continuation of RLF-100(TM) trial for treatment of COVID-19 Respiratory Failure: Trial is on track to complete enrollment in 2020 RELIEF THERAPEUTICS Holdings AG
05-Nov-2020 STRATEC WITH DOUBLE-DIGIT GROWTH IN SALES AND EARNINGS IN FIRST NINE MONTHS OF 2020 STRATEC SE
04-Nov-2020 MorphoSys to Present Data on Tafasitamab at the ASH Virtual Annual Meeting and Exposition MorphoSys AG
04-Nov-2020 Invitation to MorphoSys' Third Quarter and First 9-Month 2020 Results Conference Call on November 12, 2020 MorphoSys AG
04-Nov-2020 UBC, a Provider of Comprehensive and Integrated Care Programs, Announces Enhanced In-Workflow Services to Ease Enrollment into Patient Support Programs United BioSource Corporation
04-Nov-2020 SOTIO to Present New Data on the IL-15 Superagonist SO-C101 at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting B3C newswire
04-Nov-2020 Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows Thermo Fisher Scientific
04-Nov-2020 EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES Evotec SE
04-Nov-2020 Calliditas closes acquisition of a controlling interest in Genkyotex SA Calliditas
04-Nov-2020 Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure Showing Functional Reversal and Myocardial Rejuvenation B3C newswire
04-Nov-2020 M1 Kliniken AG: Number of treatments increase by almost 20 % in Q3-2020. Comprehensive hygiene concept ensures continuation of treatment activities. M1 Kliniken AG
04-Nov-2020 Relief Appoints J. Paul Waymack, M.D., Sc.D. as Consultant to Strengthen Management Team RELIEF THERAPEUTICS Holdings AG
04-Nov-2020 Jubilant Therapeutics to Participate in Upcoming Investor Conferences Jubilant Therapeutics Inc.
03-Nov-2020 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Akebia Therapeutics
03-Nov-2020 Cumberland Pharmaceuticals To Announce Third Quarter 2020 Financial Results Cumberland Pharmaceuticals Inc.
03-Nov-2020 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Blueprint Medicines Corporation
03-Nov-2020 Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products Sanofi
03-Nov-2020 VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan VFMCRP and ChemoCentryx
03-Nov-2020 Sanofi offers to acquire Kiadis for €308 million Sanofi
03-Nov-2020 MediClin AG: MEDICLIN publishes forecast for fiscal year 2020 MediClin AG